Springfield
Stories
-
PharmaLogic to acquire Lantheus CDMO business and Springfield facility
PharmaLogic announced a definitive agreement to acquire Lantheus' CDMO business and the Springfield, New Jersey manufacturing facility, expanding its U.S. radiopharmaceutical manufacturing capacity. The transaction includes a long-term supply agreement under which Agilera will manufacture lutetium Lu-177 dotatate for Lantheus.